Erratum to: Oral intake of a combination of glucosyl hesperidin and caffeine elicits an antiobesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial
© The Author(s). 2017
Received: 10 May 2017
Accepted: 10 May 2017
Published: 12 May 2017
The original article was published in Nutrition Journal 2016 15:6
After publication of this article  it was noticed there were errors in the paper regarding the dose and grade of glucosyl hesperidin due to miscommunications.
The composition of glucosyl hesperidin is reported as “500 mg” but this should instead be listed as “470 mg” throughout the article. Additionally, the G-hesperidin should be reported as containing 74% monoglucosyl hesperidin and residual non-glycosylated hesperidin.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.